{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:12Z","timestamp":1761514092109},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11926-017-0698-9","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T01:15:54Z","timestamp":1509326154000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases"],"prefix":"10.1007","volume":"19","author":[{"given":"Natalie","family":"McCormick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo A.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Antonio","family":"Avi\u00f1a-Zubieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"698_CR1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3111\/13696998.2016.1151433","volume":"19","author":"J Bradford Rice","year":"2016","unstructured":"Bradford Rice J, White A, Lopez A, Galebach P, Schepman P, Popelar B, et al. Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population. J Med Econ. 2016;19:649\u201354.","journal-title":"J Med Econ"},{"key":"698_CR2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/mus.23384","volume":"46","author":"D Furst","year":"2012","unstructured":"Furst D, Amato A, Iorga S, Bancroft T, Fernandes A. Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population. Muscle Nerve. 2012;46:496\u2013505.","journal-title":"Muscle Nerve"},{"key":"698_CR3","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3899\/jrheum.120600","volume":"39","author":"DE Furst","year":"2012","unstructured":"Furst DE, Fernandes AW, Iorga SR, Greth W, Bancroft T. Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population. J Rheumatol. 2012;39:2303\u20139.","journal-title":"J Rheumatol"},{"key":"698_CR4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0961203312474087","volume":"22","author":"DE Furst","year":"2013","unstructured":"Furst DE, Clarke A, Fernandes AW, Bancroft T, Gajria K, Greth W, et al. Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population. Lupus. 2013;22:268\u201378.","journal-title":"Lupus"},{"key":"698_CR5","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3899\/jrheum.150479","volume":"42","author":"K Raimundo","year":"2015","unstructured":"Raimundo K, Farr AM, Kim G, Duna G. Clinical and economic burden of antineutrophil cytoplasmic antibody-associated vasculitis in the United States. J Rheumatol. 2015;42:2383\u201391.","journal-title":"J Rheumatol"},{"key":"698_CR6","doi-asserted-by":"crossref","unstructured":"Babigumira JB, Li M, Boudreau DM, Best JH, Garrison LP. Estimating the cost of illness of giant cell arteritis in the United States. Rheumatol Ther. 2017; Available from: http:\/\/link.springer.com\/10.1007\/s40744-017-0052-8","DOI":"10.1007\/s40744-017-0052-8"},{"key":"698_CR7","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/rheumatology\/ket238","volume":"52","author":"N Yilmaz","year":"2013","unstructured":"Yilmaz N, Can M, Oner FA, Kalfa M, Emmungil H, Karadag O, et al. Impaired quality of life, disability and mental health in Takayasu\u2019s arteritis. Rheumatology. 2013;52:1898\u2013904.","journal-title":"Rheumatology"},{"key":"698_CR8","doi-asserted-by":"crossref","unstructured":"Abularrage CJ, Slidell MB, Sidawy AN, Kreishman P, Amdur RL, Arora S. Quality of life of patients with Takayasu\u2019s arteritis. J Vasc Surg. 2008;47:131\u20136.","DOI":"10.1016\/j.jvs.2007.09.044"},{"key":"698_CR9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3899\/jrheum.080281","volume":"36","author":"M Hudson","year":"2009","unstructured":"Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, et al. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol. 2009;36:768\u201372.","journal-title":"J Rheumatol"},{"key":"698_CR10","first-page":"1706","volume":"32","author":"M Jolly","year":"2005","unstructured":"Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005;32:1706\u20138.","journal-title":"J Rheumatol"},{"key":"698_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/art.24235","volume":"61","author":"DM Carpenter","year":"2009","unstructured":"Carpenter DM, Thorpe CT, Lewis M, Devellis RF, Hogan SL. Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum. 2009;61:259\u201365.","journal-title":"Arthritis Rheum"},{"key":"698_CR12","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3899\/jrheum.100167","volume":"37","author":"M Faurschou","year":"2010","unstructured":"Faurschou M, Sigaard L, Bjorner JB, Baslund B. Impaired health-related quality of life in patients treated for Wegener\u2019s granulomatosis. J Rheumatol. 2010;37:2081\u20135.","journal-title":"J Rheumatol"},{"key":"698_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/ken477","volume":"48","author":"K Baker","year":"2009","unstructured":"Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatol. Oxf. Engl. 2009;48:281\u20134.","journal-title":"Rheumatol. Oxf. Engl."},{"key":"698_CR14","first-page":"S-206","volume":"32","author":"S Decuman","year":"2014","unstructured":"Decuman S, Smith V, Verhaeghe STL, Van Hecke A, De Keyser F. Work participation in patients with systemic sclerosis: a systematic review. Clin Exp Rheumatol. 2014;32:S-206\u201313.","journal-title":"Clin Exp Rheumatol"},{"key":"698_CR15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5014\/ajot.63.2.214","volume":"63","author":"J Poole","year":"2009","unstructured":"Poole J, Willer K, Mendelson C. Occupation of motherhood: challenges for mothers with scleroderma. Am J Occup Ther. 2009;63:214\u20139.","journal-title":"Am J Occup Ther"},{"key":"698_CR16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10067-011-1929-5","volume":"31","author":"J Poole","year":"2012","unstructured":"Poole J, Rymek-Gmytrasiewicz M, Mendelson C, Sanders M, Skipper B. Parenting: the forgotten role of women living with systemic lupus erythematosus. Clin Rheumatol. 2012;31:995\u20131000.","journal-title":"Clin Rheumatol"},{"key":"698_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msc.197","volume":"9","author":"JL Poole","year":"2011","unstructured":"Poole JL, Willer K, Mendelson C, Sanders M, Skipper B. Perceived parenting ability and systemic sclerosis. Musculoskeletal Care. 2011;9:32\u201340.","journal-title":"Musculoskeletal Care"},{"key":"698_CR18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/09638288.2014.944624","volume":"37","author":"JL Poole","year":"2015","unstructured":"Poole JL, Chandrasekaran A, Hildebrand K, Skipper B. Participation in life situations by persons with systemic sclerosis. Disabil Rehabil. 2015;37:842\u20135.","journal-title":"Disabil Rehabil"},{"key":"698_CR19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.23536","volume":"59","author":"P Katz","year":"2008","unstructured":"Katz P, Morris A, Trupin L, Yazdany J, Yelin E. Disability in valued life activities among individuals with systemic lupus erythematosus. Arthritis Rheum. 2008;59:465\u201373.","journal-title":"Arthritis Rheum"},{"key":"698_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3899\/jrheum.160932","volume":"44","author":"T Mandl","year":"2017","unstructured":"\u2022\u2022 Mandl T, J\u00f8rgensen TS, Skougaard M, Olsson P, Kristensen L-E. Work disability in newly diagnosed patients with primary Sj\u00f6gren syndrome. J Rheumatol. 2017;44:209\u201315. Linked data from a clinical registry, with population-based social insurance data for incident cases (SjS and SSc) and a sample of the general population, in order to assess work disability longitudinally from the time of SjS\/SSc diagnosis.","journal-title":"J Rheumatol"},{"key":"698_CR21","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3899\/jrheum.081237","volume":"36","author":"M Hudson","year":"2009","unstructured":"Hudson M, Steele R, Lu Y, Thombs BD, Group CSR, Baron M. Work disability in systemic sclerosis. J Rheumatol. 2009;36:2481\u20136.","journal-title":"J Rheumatol"},{"key":"698_CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.24086","volume":"61","author":"S Bernatsky","year":"2009","unstructured":"Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, Leclercq S, et al. The cost of systemic sclerosis. Arthritis Rheum. 2009;61:119\u201323.","journal-title":"Arthritis Rheum"},{"key":"698_CR23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keh229","volume":"43","author":"AE Clarke","year":"2004","unstructured":"Clarke AE, Petri M, Manzi S, Isenberg DA, Gordon C, Sen\u00e9cal J-L, et al. The systemic lupus erythematosus tri-nation study: absence of a link between health resource use and health outcome. Rheumatology. 2004;43:1016\u201324.","journal-title":"Rheumatology"},{"key":"698_CR24","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/art.1780361109","volume":"36","author":"A Clarke","year":"1993","unstructured":"Clarke A, Esdaile J, Bloch B, Lacaille D, Danoff D, Fries J. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum. 1993;36:1548\u201359.","journal-title":"Arthritis Rheum"},{"key":"698_CR25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/acr.20410","volume":"63","author":"TY Zhu","year":"2011","unstructured":"Zhu TY, Tam LS, Li EK. Cost-of-illness studies in systemic lupus erythematosus: a systematic review. Arthritis Care Res. 2011;63:751\u201360.","journal-title":"Arthritis Care Res"},{"key":"698_CR26","first-page":"S116","volume":"30","author":"G Turchetti","year":"2012","unstructured":"Turchetti G, Yazdany J, Palla I, Yelin E, Mosca M. Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider. Clin Exp Rheumatol. 2012;30:S116\u201322.","journal-title":"Clin Exp Rheumatol"},{"key":"698_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40273-012-0007-4","volume":"31","author":"R Meacock","year":"2013","unstructured":"Meacock R, Dale N, Harrison MJ. The humanistic and economic burden of systemic lupus erythematosus: a systematic review. PharmacoEconomics. 2013;31:49\u201361.","journal-title":"PharmacoEconomics"},{"key":"698_CR28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.berh.2012.08.006","volume":"26","author":"P Panopalis","year":"2012","unstructured":"Panopalis P, Clarke AE, Yelin E. The economic burden of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2012;26:695\u2013704.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"698_CR29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1586\/14737167.6.5.563","volume":"6","author":"A Clarke","year":"2006","unstructured":"Clarke A, Panopalis P. Systemic lupus erythematosus: clinical manifestations, treatment and economics. Expert Rev Pharmacoecon Outcomes Res. 2006;6:563\u201375.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"698_CR30","first-page":"S154","volume":"30","author":"L Trieste","year":"2012","unstructured":"Trieste L, Palla I, Baldini C, Talarico R, D\u2019Angiolella L, Mosca M, et al. Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol. 2012;30:S154\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"698_CR31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/rheumatology\/ker523","volume":"51","author":"AA Schouffoer","year":"2012","unstructured":"Schouffoer AA, Schoones JW, Terwee CB, Vliet Vlieland TPM. Work status and its determinants among patients with systemic sclerosis: a systematic review. Rheumatol Oxf Engl. 2012;51:1304\u201314.","journal-title":"Rheumatol Oxf Engl"},{"key":"698_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.socscimed.2010.10.026","volume":"72","author":"W Zhang","year":"2011","unstructured":"Zhang W, Bansback N, Anis AH. Measuring and valuing productivity loss due to poor health: a critical review. Soc Sci Med. 2011;72:185\u201392.","journal-title":"Soc Sci Med"},{"key":"698_CR33","volume-title":"Methods for the economic evaluation of health care programmes","year":"2007","unstructured":"Drummond MF, editor. Methods for the economic evaluation of health care programmes. 3. ed., reprint ed. Oxford: Oxford Univ. Press; 2007.","edition":"3. ed., reprint"},{"key":"698_CR34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","volume":"29","author":"A Larg","year":"2011","unstructured":"Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. PharmacoEconomics. 2011;29:653\u201371.","journal-title":"PharmacoEconomics"},{"key":"698_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40273-014-0132-3","volume":"32","author":"M Krol","year":"2014","unstructured":"Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. PharmacoEconomics. 2014;32:335\u201344.","journal-title":"PharmacoEconomics"},{"key":"698_CR36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3899\/jrheum.090734","volume":"37","author":"SJ Bowman","year":"2010","unstructured":"Bowman SJ, Pierre YS, Sutcliffe N, Isenberg DA, Goldblatt F, Price E, et al. Estimating indirect costs in primary Sjogren\u2019s syndrome. J Rheumatol. 2010;37:1010\u20135.","journal-title":"J Rheumatol"},{"key":"698_CR37","first-page":"2597","volume":"27","author":"AE Clarke","year":"2000","unstructured":"Clarke AE, Penrod J, Pierre YS, Petri MA, Manzi S, Isenberg DA, et al. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group J Rheumatol. 2000;27:2597\u2013604.","journal-title":"Tri-Nation Study Group J Rheumatol"},{"key":"698_CR38","first-page":"2113","volume":"152","author":"K Bjerrum","year":"1990","unstructured":"Bjerrum K, Prause JU. [Sociomedical aspects of primary Sj\u00f6gren\u2019s syndrome]. Ugeskr. Laeger. 1990;152:2113\u20136.","journal-title":"Laeger"},{"key":"698_CR39","first-page":"245","volume":"55","author":"A Belotti Masserini","year":"2003","unstructured":"Belotti Masserini A, Zeni S, Cossutta R, Soldi A, Fantini F. Cost-of-illness in systemic sclerosis: a retrospective study of an Italian cohort of 106 patients. Reumatismo. 2003;55:245\u201355.","journal-title":"Reumatismo"},{"key":"698_CR40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1477-7525-7-46","volume":"7","author":"B Segal","year":"2009","unstructured":"Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjogren\u2019s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;7:46.","journal-title":"Health Qual Life Outcomes"},{"key":"698_CR41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/rheumatology\/kep141","volume":"48","author":"JM Meijer","year":"2009","unstructured":"Meijer JM, Meiners PM, Huddleston Slater JJR, Spijkervet FKL, Kallenberg CGM, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren\u2019s syndrome. Rheumatology. 2009;48:1077\u201382.","journal-title":"Rheumatology"},{"key":"698_CR42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/acr.20342","volume":"63","author":"A B\u00e9rezn\u00e9","year":"2011","unstructured":"B\u00e9rezn\u00e9 A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, et al. Impact of systemic sclerasis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res. 2011;63:277\u201385.","journal-title":"Arthritis Care Res"},{"key":"698_CR43","first-page":"721","volume":"32","author":"W Mau","year":"2005","unstructured":"Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol. 2005;32:721\u20138.","journal-title":"J Rheumatol"},{"key":"698_CR44","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/rheumatology\/keq165","volume":"49","author":"T Minier","year":"2010","unstructured":"Minier T, P\u00e9ntek M, Brodszky V, Ecseki A, K\u00e1rp\u00e1ti K, Polg\u00e1r A, et al. Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology. 2010;49:1920\u20138.","journal-title":"Rheumatology"},{"key":"698_CR45","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kep400","volume":"49","author":"C Nguyen","year":"2010","unstructured":"Nguyen C, Poiraudeau S, Mestre-Stanislas C, Rannou F, B\u00e9rezn\u00e9 A, Papelard A, et al. Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. Rheumatol. Oxf. Engl. 2010;49:982\u20139.","journal-title":"Rheumatol. Oxf. Engl."},{"key":"698_CR46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1874312900802010044","volume":"2","author":"JM Ouimet","year":"2008","unstructured":"Ouimet JM, Pope JE, Gutmanis I, Koval J. Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J. 2008;2:44\u201352.","journal-title":"Open Rheumatol J"},{"key":"698_CR47","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/rheumatology\/ken359","volume":"47","author":"G Sandqvist","year":"2008","unstructured":"Sandqvist G, Scheja A, Eklund M. Working ability in relation to disease severity, everyday occupations and well-being in women with limited systemic sclerosis. Rheumatol. Oxf. Engl. 2008;47:1708\u201311.","journal-title":"Rheumatol. Oxf. Engl."},{"key":"698_CR48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/rheumatology\/keq145","volume":"49","author":"G Sandqvist","year":"2010","unstructured":"Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology. 2010;49:1739\u201346.","journal-title":"Rheumatology"},{"key":"698_CR49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semarthrit.2011.01.002","volume":"41","author":"R Sharif","year":"2011","unstructured":"Sharif R, Mayes MD, Nicassio PM, Gonzalez EB, Draeger H, McNearney TA, et al. Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort. Semin Arthritis Rheum. 2011;41:38\u201347.","journal-title":"Semin Arthritis Rheum"},{"key":"698_CR50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-0172(97)80008-X","volume":"27","author":"L Wilson","year":"1997","unstructured":"Wilson L. Cost-of-illness of scleroderma: the case for rare diseases. Semin Arthritis Rheum. 1997;27:73\u201384.","journal-title":"Semin Arthritis Rheum"},{"key":"698_CR51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.10341","volume":"47","author":"MM Boomsma","year":"2002","unstructured":"Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW. Patients\u2019 perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener\u2019s granulomatosis. Arthritis Rheum. 2002;47:196\u2013201.","journal-title":"Arthritis Rheum"},{"key":"698_CR52","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/1529-0131(199911)42:11<2495::AID-ANR35>3.0.CO;2-A","volume":"42","author":"MM Boomsma","year":"1999","unstructured":"Boomsma MM, Stegeman CA, Tervaert JW. Comparison of Dutch and US patients\u2019 perceptions of the effects of Wegener\u2019s granulomatosis on health, function, income, and interpersonal relationships: comment on the article by Hoffman et al. Arthritis Rheum. 1999;42:2495\u20137.","journal-title":"Arthritis Rheum"},{"key":"698_CR53","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/1529-0131(199812)41:12<2257::AID-ART22>3.0.CO;2-K","volume":"41","author":"GS Hoffman","year":"1998","unstructured":"Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K. Wegener\u2019s granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum. 1998;41:2257\u201362.","journal-title":"Arthritis Rheum"},{"key":"698_CR54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.10458","volume":"47","author":"E Reinhold-Keller","year":"2002","unstructured":"Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter HH, Raspe HH, et al. Effect of Wegener\u2019s granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40\u00a0years at diagnosis. Arthritis Rheum. 2002;47:320\u20135.","journal-title":"Arthritis Rheum"},{"key":"698_CR55","doi-asserted-by":"crossref","unstructured":"\u2022 Regardt M, Welin Henriksson E, Sandqvist J, Lundberg IE, Schult M-L. Work ability in patients with polymyositis and dermatomyositis: an explorative and descriptive study. Work Read Mass. 2015;53:265\u201377. One of the first-known publications on productivity losses in PM\/DM","DOI":"10.3233\/WOR-152127"},{"key":"698_CR56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/ker208","volume":"51","author":"G Westhoff","year":"2012","unstructured":"Westhoff G, Dorner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjogren\u2019s syndrome: results from a cohort study. Rheumatology. 2012;51:262\u20139.","journal-title":"Rheumatology"},{"key":"698_CR57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/ker288","volume":"51","author":"S Decuman","year":"2012","unstructured":"Decuman S, Smith V, Verhaeghe S, Deschepper E, Vermeiren F, Keyser FD. Work participation and work transition in patients with systemic sclerosis: a cross-sectional study. Rheumatology. 2012;51:297\u2013304.","journal-title":"Rheumatology"},{"key":"698_CR58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/14737167.2015.1065733","volume":"15","author":"PP Kawalec","year":"2015","unstructured":"Kawalec PP, Malinowski KP. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland. Expert Rev. Pharmacoecon. Outcomes Res. 2015;15:667\u201373.","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"698_CR59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10198-016-0789-y","volume":"17","author":"J L\u00f3pez-Bastida","year":"2016","unstructured":"\u2022 The BURQOL-RD Research Network, L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, et al. Social\/economic costs and health-related quality of life in patients with scleroderma in Europe. Eur J Health Econ. 2016;17:109\u201317. Recruited patients and their caregivers through patient organisations (instead of academic medical centres) and a rare diseases registry, and computed the productivity costs of SSc separately for seven European countries.","journal-title":"Eur J Health Econ"},{"issue":"Suppl 100","key":"698_CR60","first-page":"79","volume":"34","author":"K Morrisroe","year":"2016","unstructured":"Morrisroe K, Huq M, Stevens W, Rabusa C, Proudman SM, Nikpour M, et al. Determinants of unemployment amongst Australian systemic sclerosis patients: results from a multicentre cohort study. Clin Exp Rheumatol. 2016;34(Suppl 100):79\u201384.","journal-title":"Clin Exp Rheumatol"},{"key":"698_CR61","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3899\/jrheum.150023","volume":"42","author":"G Sandqvist","year":"2015","unstructured":"\u2022\u2022 Sandqvist G, Hesselstrand R, Petersson IF, Kristensen LE. Work disability in early systemic sclerosis: a longitudinal population-based cohort study. J Rheumatol. 2015;42:1794\u2013800. Linked data from a clinical registry, with population-based social insurance data for incident cases (SjS and SSc) and a sample of the general population, in order to assess work disability longitudinally from the time of SjS\/SSc diagnosis","journal-title":"J Rheumatol"},{"key":"698_CR62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/acr.20676","volume":"64","author":"MK Singh","year":"2012","unstructured":"Singh MK, Clements PJ, Furst DE, Maranian P, Khanna D. Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study. Arthritis Care Res. 2012;64:176\u201383.","journal-title":"Arthritis Care Res"},{"key":"698_CR63","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/ket483","volume":"53","author":"N Basu","year":"2014","unstructured":"Basu N, McClean A, Harper L, Amft EN, Dhaun N, Luqmani RA, et al. Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology. 2014;53:953\u20136.","journal-title":"Rheumatology"},{"key":"698_CR64","first-page":"S111","volume":"34","author":"LJ Barra","year":"2016","unstructured":"Barra LJ, Bateman EA, Rohekar S, Pagnoux C, Moradizadeh M. Assessment of work limitations and disability in systemic vasculitis. Clin Exp Rheumatol. 2016;34:S111\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"698_CR65","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Posada-de-la-Paz M, Serrano-Aguilar P. Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain. Arthritis Care Res. 2013","DOI":"10.1002\/acr.22167"},{"key":"698_CR66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/03009742.2014.976653","volume":"44","author":"K Chevreul","year":"2015","unstructured":"Chevreul K, Brigham KB, Gandr\u00e9 C, Mouthon L, BURQOL-RD Research Network. The economic burden and health-related quality of life associated with systemic sclerosis in France. Scand J Rheumatol. 2015;44:238\u201346.","journal-title":"Scand J Rheumatol"},{"key":"698_CR67","doi-asserted-by":"crossref","unstructured":"Li X, Gignac MAM, Anis AH. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work: Med. Care. 2006;44:304\u201310.","DOI":"10.1097\/01.mlr.0000204257.25875.04"},{"key":"698_CR68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/art.24213","volume":"61","author":"E Yelin","year":"2009","unstructured":"Yelin E, Tonner C, Trupin L, Panopalis P, Yazdany J, Julian L, et al. Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample. Arthritis Rheum. 2009;61:247\u201358.","journal-title":"Arthritis Rheum"},{"key":"698_CR69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/rheumatology\/ker401","volume":"51","author":"E Nikiphorou","year":"2012","unstructured":"Nikiphorou E, Guh D, Bansback N, Zhang W, Dixey J, Williams P, et al. Work disability rates in RA. Results from an inception cohort with 24\u00a0years follow-up. Rheumatology. 2012;51:385\u201392.","journal-title":"Rheumatology"},{"key":"698_CR70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/03009742.2015.1126344","volume":"45","author":"E Hallert","year":"2016","unstructured":"Hallert E, Husberg M, Kalkan A, Bernfort L. Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996\u201398 and 2006\u201309. Scand J Rheumatol. 2016;45:371\u20138.","journal-title":"Scand J Rheumatol"},{"key":"698_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4530104","volume":"2017","author":"R O\u2019Riordan","year":"2017","unstructured":"O\u2019Riordan R, Doran M, Connolly D. Fatigue and activity management education for individuals with systemic lupus erythematosus. Occup Ther Int. 2017;2017:1\u201311.","journal-title":"Occup Ther Int"},{"key":"698_CR72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/acr.22675","volume":"68","author":"T Pino-Sede\u00f1o del","year":"2016","unstructured":"del Pino-Sede\u00f1o T, Trujillo-Mart\u00edn MM, Ruiz-Irastorza G, Cuellar-Pompa L, de Pascual-Medina AM, Serrano-Aguilar P, et al. Effectiveness of nonpharmacologic interventions for decreasing fatigue in adults with systemic lupus erythematosus: a systematic review: treating fatigue in adults with SLE. Arthritis Care Res. 2016;68:141\u20138.","journal-title":"Arthritis Care Res"},{"key":"698_CR73","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/kem004","volume":"46","author":"BE Strombeck","year":"2007","unstructured":"Strombeck BE, Theander E, Jacobsson LTH. Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren\u2019s syndrome. Rheumatology. 2007;46:868\u201371.","journal-title":"Rheumatology"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-017-0698-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T05:21:07Z","timestamp":1570252867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-017-0698-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s11926-017-0698-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]},"article-number":"72"}}